एस्टोनिया - एस्टोनियाई - Ravimiamet

orion corporation - salbutamool - inhalatsioonipulber - 200mcg 1annus 200annus 1tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

orion corporation - salbutamool - inhalatsioonipulber - 100mcg 1annus 200annus 1tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

pharmaceutical works polfa in pabiance joint stock co - sulfametoksasool+trimetoprim - tablett - 100mg+20mg 20tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

pharmaceutical works polfa in pabiance joint stock co - sulfametoksasool+trimetoprim - tablett - 800mg+160mg 10tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

pharmaceutical works polfa in pabiance joint stock co - sulfametoksasool+trimetoprim - tablett - 400mg+80mg 28tk; 400mg+80mg 20tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

warsaw pharmaceutical works polfa s.a. - sulfametoksasool+trimetoprim - infusioonilahuse kontsentraat - 80mg+16mg 1ml 5ml 10tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

adamed pharma s.a. - sulfametoksasool+trimetoprim - tablett - 800mg+160mg 10tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

adamed pharma s.a. - sulfametoksasool+trimetoprim - tablett - 400mg+80mg 28tk

एस्टोनिया - एस्टोनियाई - Ecolab

ecolab deutschland gmbh -

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.